Yasuko Uchigata

Institute for Advanced Study — Germany

Biochemistry, Genetics and Molecular Biology · Life Sciences

47h-index7.8kcitations302works2.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Diabetes and associated disorders(116), Diabetes Management and Research(98), Pancreatic function and diabetes(71), Diabetes Treatment and Management(40), Chronic Kidney Disease and Diabetes(23)

Publications299 total

Effect of a Multifactorial Intervention on Retinopathy in People With Type 2 Diabetes
JAMA Ophthalmology·2025· 2 citedOpen Access
Prevalence and risk factors for skeletal muscle mass loss in individuals with type 1 diabetes
Diabetology International·2024· 2 citedOpen Access
Correction: ƩexcessA1C index, the sum of yearly excess HbA1c values during the total period of diabetes, may have the potential to predict retinopathy by a linear regression setting regardless of duration in type 1 diabetes: a subgroup analysis of DCCT/EDIC data
Diabetology International·2023Open Access
ƩexcessA1C index, the sum of yearly excess HbA1c values during the total period of diabetes, may have the potential to predict retinopathy by a linear regression setting regardless of duration in type 1 diabetes: a subgroup analysis of DCCT/EDIC data
Diabetology International·2023· 1 citedOpen Access
Direct Oral Anticoagulants Affect Activated Clotting Time During and Bleeding Events After Percutaneous Coronary Intervention
The American Journal of Cardiology·2023· 3 cited
Direct Oral Anticoagulants Affect Activated Clotting Time During and Bleeding Events After Percutaneous Coronary Intervention
2023· 1 citedOpen Access
Risk of fetal undergrowth in the management of gestational diabetes mellitus in Japan
Journal of Diabetes Investigation·2023· 11 citedOpen Access
Update information on type 1 diabetes in children/adolescents and adults
Journal of Diabetes Investigation·2023· 2 citedOpen Access
[Successful treatment of acute promyelocytic leukemia with all-trans retinoic acid on hemodialysis for acute renal failure].
PubMed·2023· 1 cited
Prognostic Impact of Statins on Patients With Peripheral Artery Disease With Elevated C-Reactive Protein Levels
The American Journal of Cardiology·2022· 4 cited
Factors associated with hypoglycemia unawareness and severe hypoglycemia in type 1 diabetes mellitus patients
Journal of Diabetes Investigation·2022· 16 citedOpen Access
REGN-COV2 antibody cocktail in patients with SARS-CoV-2: Observational study from a single institution in Japan
Journal of Infection and Chemotherapy·2022· 3 citedOpen Access
Is Chronic Kidney Disease Affecting the Postoperative Complications of Vitrectomy for Proliferative Diabetic Retinopathy?
Journal of Clinical Medicine·2021· 11 citedOpen Access
Universal testing for SARS-CoV-2 infection on admission among hospitalized emergency patients: A survey report from a single facility in Tokyo
Infection Disease & Health·2021· 1 citedOpen Access
Recurrent Hypoglycemia Due to a High Titer of Insulin Antibody in Response to Exogenous Insulin Administration in Two Cases of Type 1 Diabetes
Internal Medicine·2021· 3 citedOpen Access
Psychological Effects on Healthcare Workers during the COVID-19 Outbreak: A Single-center Study at a Tertiary Hospital in Tokyo, Japan
Internal Medicine·2021· 11 citedOpen Access
Cross-sectional and longitudinal associations between dipstick hematuria and chronic kidney disease in patients with type 2 diabetes
Diabetes Research and Clinical Practice·2020· 2 cited
Usefulness of glycated albumin as a predictor of mortality in chronic hemodialysis patients with diabetes: a multi-center, prospective cohort study
Renal Replacement Therapy·2020· 4 citedOpen Access
Efficacy and safety of dapagliflozin in Japanese patients with inadequately controlled type 1 diabetes (DEPICT‐5): 52‐week results from a randomized, open‐label, phase III clinical trial
Diabetes Obesity and Metabolism·2019· 27 citedOpen Access
Author response for "Efficacy and safety of dapagliflozin in Japanese patients with inadequately controlled type 1 diabetes (DEPICT‐5): 52‐week results from a randomized, open‐label, phase III clinical trial"
2019
page 1 of 15Next →

Frequent Co-authors

Yasuhiko Iwamoto(14), Eiji Kawasaki(10), Akihisa Imagawa(8), Toshiaki Hanafusa(8), Tetsuro Kobayashi(8), Hiroshi Yamamoto(7), Akira Shimada(7), Junnosuke Miura(7), Ikki Shimizu(6), Hideichi Makino(6), Taro Maruyama(6), Yasue Omori(6), Takuya Awata(5), Hiroshi Ikegami(5), Yumiko Kawabata(5), Katsushi Tokunaga(5), Tetsuya Babazono(5), Haruhiko Osawa(4), Kazuma Takahashi(4), Shoji Kuwata(4)